Navigation Links
deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
Date:7/1/2009

g>, the University of Heidelberg, the University of Bonn, the University Medical Center of Utrecht, Nijmegen Medical Center, the University of Verona, the Duke University Center for Population Genomics and Pharmacogenetics and the University of Sichuan, China. Follow up cohorts included those from Aarhus University, the National Serum Institute, and Bispebjerg and Glostrup hospitals, Denmark; Semmelweis University, Budapest; the Mental Health Research Center of the Russian Academy of Sciences; the Universities of Valencia and Santiago de Compostela, and the Hospital General Universitario Gregorio Maranon, Madrid, Spain; The Northern Finland Birth Cohort; Karolinska Institutet, Stockholm; Universities of Amsterdam, Utrecht and Maastricht, the Netherlands. The institutions comprising the ISC and MGS can be found in papers published concurrently with the present study in the online edition of Nature.

Funding for the work included in this study was provided by the European Union through the SGENE consortium (www.SGENE.eu), by grants LSHM-CT-2006-037761, PIAP-GA-2008-218251, and HEALTH-F2-2009-223423; The U.S. National Institutes of Health; and the National Genomic Network of Germany.

About deCODE

deCODE is a bio-pharmaceutical company developing drugs and DNA-based tests to improve the treatment, diagnosis and prevention of common diseases. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds targeting the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 modulators with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader in human genetics, and has identified key variations in the genome (SNPs) conferring increased ris
'/>"/>

SOURCE DeCODE Genetics Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Major deCODE-led Study Underscores Role of the Brain in Obesity
2. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
3. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
4. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
5. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
6. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
8. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
9. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
10. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
11. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...IN, China, Nov. 25 /PRNewswire-Asia-FirstCall/ -- ...l" or "the Company") (Nasdaq: CSKI ), a,leading f...and producing,over-the-counter drugs in the People... the Company recently passed the Chinese National ...ological Products ("ICPBP") examination,for two of...
(Date:11/25/2009)..., Mass., Nov. 25 According to Mill...on medical technology market intelligence, the nea...es will continue to see rapid growth over the next...MRG,s US Markets for Trauma Devices 2010 repor...c over the next five years, with competitors intro...
(Date:11/25/2009)... The Netherlands and JOHANNESBURG, November 25 /PR...sion and Pyxis Discovery announced today,that they...market both,companies, services. , Pyxis,...covery expertise,will be coupled with iThemba,s se...chemistry support to projects identified through P...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Pancreatic cancer risk decreased by one anti diabetic therapy increased by others 53409 1Pancreatic cancer risk decreased by one anti diabetic therapy increased by others 53409 2Dementia induced and blocked in Parkinsons fly model 53406 1Dementia induced and blocked in Parkinsons fly model 53406 2Dementia induced and blocked in Parkinsons fly model 53406 3House Tri Committee Bill Would Hurt Patients and Kill Jobs 53405 1House Tri Committee Bill Would Hurt Patients and Kill Jobs 53405 2House Tri Committee Bill Would Hurt Patients and Kill Jobs 53405 3
...UPERTINO, Calif., Aug. 12 DURECT Corporation,(Nas...Drug Administration,(FDA) has accepted the New Dru...ity Review. The FDA typically grants Priority Revi...emonstrate significant improvements,compared to ma...w of a drug,with Priority Review status is six mon...
...wing to Well-Established and Effective Insulin-Bas... 2017, According to a New Report from Decision ...ss., Aug. 12 Decision Resources, one of the,world...eutical and,healthcare issues, finds that the most...es market will be the shift in the standard of car...
Other Medicine Technology:REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market 2
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 ...ed that Blair Lambert, CFO/COO, will present at th...held at the May Fair Hotel in London, England, on ..., To listen to a live broadcast of The Gymboree ...se log on to www.gymboree.com, click on "Our Compa...
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswir...rofessional cycling team dedicated to ethical spor... champions, announced today that it will become Te...ions Optical as a new sponsor of the team. Transit...f adaptive eyewear, offering the most advanced pho...
(Date:11/27/2009)... XenaCare Holdings has announced t...tis Foundation, one of the largest nonprofit organ...c health education. , Del...e Holdings, Inc. (OTCBB: XCHO), a company speciali...onsumer healthcare products, has announced today t...
(Date:11/27/2009)...ates to bring unprecedented medical, economic burd...(HealthDay News) -- The number of people with diab...er the next 25 years, a new study predicts. , T...llion people with the disease, up from 23.7 millio...ing people with diabetes will triple, the study al...
(Date:11/27/2009)... Voyant Health™ announced to...has licensed its TraumaCad Enterprise orthopedic t...ow solution. , (PRWEB) No...today that Spectrum Health (Grand Rapids, Michigan... templating solution and its TraumaCad Extend work...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...ey, California have come out with a tremendous tec... information held in store in the human genome. Th...dowing". An analysis through this technique helps ... patterns' that identify these primate families un...
...t cancer are put off just with the news and then f...akes 6 weeks, disrupts their world completely. How...asier and less disruptive way of treating these ca...doctors will now be able to deliver the same cance...
...attempt to find out how various eating styles were...mpared the blood pressures of meat eaters, fish ea...ch were published in Public Health Nutrition, show...blood pressure and others with normal blood pressu...
...are one of the most exquisite pieces of engineerin...the eyes become vulnerable to a debilitating degen...eaking down, which ultimately might lead to blindn...ough nutrients that work as antioxidants. The...
... sharp rise in the use of alternative treatments a...entifically document the effects of hundreds of he...now, there was// no easy access to current, compre...ill provide up-to-date information on the safety a...
...y of us, though very annoying, are just a harmless...for many sick people who have weakened immune syst...ttacks launched against their blood vessels and in...ering them ineffective for treatment of several se...
Other Medicine News:Health News:Primates reveal a new dimension to human genome, 2Health News:Cut meat to cut blood pressure 2Health News:New insights into herbal supplements 2Health News:Fight against Fungus - A new ray of hope 2
RESTASIS®
LADARWave® Aberrometer
ZYMAR™ 2.5 mL
REFRESH TEARS®
Medicine Products: